Avera Pharmaceuticals - Therapeutic Interests

Avera is a specialty pharmaceutical company with interest in neurosciences, pain and infectious diseases.

Within the neurosciences therapeutic arena, Avera has an ongoing interest and expertise in anxiety, neurovisceral disorders, mood disorders, psychotic disorders, cognitive impairment, multiple sclerosis, and pain. Within these therapeutic areas, Avera is currently developing compounds for Irritable Bowel Syndrome, Overactive Bladder, Cognitive Impairment Associated with Schizophrenia and Alzheimer’s Dementia.

In the pain therapeutic arena, both acute pain and chronic pain are of interest to Avera. Potential therapies for both acute and chronic pain, including neuropathic pain are an ongoing medical need. Avera is interest in therapies aimed at preventing and treating pain.

In the infectious diseases area Avera is interested in novel drugs to treat serious, chronic and acute infectious diseases where there is a significant need for improved therapy.

If you have a partnering opportunity that you would like to discuss, please contact Business Development.